Table II.
SS (ng/l) | VIP (ng/l) | |||
---|---|---|---|---|
|
|
|||
Group | Blood | Sigmoid colon | Blood | Sigmoid colon |
Control | 27.43±18.45 | 18.21±6.24 | 35.81±19.30 | 725.43±179.23 |
IBS-C | 170.23±38.47a | 256.20±178.41a | 51.73±29.53a | 1,234.07±472.83a |
IBS-D | 59.82±20.63ab | 35.73±17.47ab | 53.34±21.64ac | 1,210.75±384.73ac |
Data are presented as the mean ± standard deviation.
P<0.05 versus the control group;
P<0.05 versus the constipation predominant irritable bowel syndrome (IBS-C) group;
P>0.05 versus the IBS-C group.
SS, somatostatin; VIP, vasoactive intestinal peptide. IBS-D, diarrhea predominant IBS.